LUPETTI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.352
EU - Europa 3.093
AS - Asia 895
AF - Africa 66
SA - Sud America 10
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.429
Nazione #
US - Stati Uniti d'America 6.207
IT - Italia 1.282
SE - Svezia 483
CN - Cina 452
DE - Germania 364
BG - Bulgaria 273
GB - Regno Unito 145
VN - Vietnam 144
CA - Canada 141
UA - Ucraina 137
TR - Turchia 96
FR - Francia 91
FI - Finlandia 88
SG - Singapore 74
AT - Austria 62
CH - Svizzera 47
HK - Hong Kong 45
IN - India 44
CI - Costa d'Avorio 42
RU - Federazione Russa 40
BE - Belgio 22
PL - Polonia 15
NL - Olanda 13
ES - Italia 11
NG - Nigeria 9
JP - Giappone 8
SN - Senegal 8
AU - Australia 7
ID - Indonesia 7
BR - Brasile 5
PH - Filippine 5
EG - Egitto 4
EU - Europa 4
IL - Israele 4
CZ - Repubblica Ceca 3
GR - Grecia 3
HU - Ungheria 3
IE - Irlanda 3
IR - Iran 3
MY - Malesia 3
PK - Pakistan 3
CO - Colombia 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
KR - Corea 2
TH - Thailandia 2
A1 - Anonimo 1
AM - Armenia 1
BN - Brunei Darussalam 1
CL - Cile 1
EC - Ecuador 1
HR - Croazia 1
IQ - Iraq 1
KE - Kenya 1
MA - Marocco 1
MX - Messico 1
NA - Namibia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
Totale 10.429
Città #
Woodbridge 779
Houston 774
Fairfield 718
Ann Arbor 674
Chandler 507
Ashburn 405
Sofia 273
Seattle 268
Milan 260
Wilmington 256
Serra 239
Cambridge 229
Beijing 179
New York 173
Jacksonville 170
Princeton 141
Ottawa 136
Lawrence 112
Medford 104
Frankfurt am Main 103
Bremen 98
Izmir 92
Nanjing 88
Pisa 76
Des Moines 68
Dearborn 60
Dong Ket 57
Florence 53
Vienna 52
Bern 47
Rome 45
Hong Kong 43
Abidjan 42
San Diego 42
London 34
Nanchang 34
Marseille 33
Los Angeles 32
Jüchen 30
Redwood City 23
Singapore 23
Brussels 20
Pune 20
Boulder 19
Kunming 17
Shenyang 17
Jiaxing 16
Hebei 15
Changsha 13
Lancaster 13
Warsaw 13
Washington 12
Hefei 11
Phoenix 11
Hangzhou 9
Lagos 9
Norwalk 9
Quarrata 9
Dakar 8
Ogden 8
Auburn Hills 7
Como 7
Jakarta 7
Orange 7
Bologna 6
Changchun 6
Guangzhou 6
Jinan 6
Maddaloni 6
Tianjin 6
Verona 6
Nürnberg 5
Voghera 5
Amsterdam 4
Chicago 4
Lappeenranta 4
Lucca 4
Naples 4
Paris 4
Pian Camuno 4
San Mauro Pascoli 4
Viareggio 4
Berlin 3
Budapest 3
Calci 3
Cascina 3
Chengdu 3
Cosenza 3
Esslingen am Neckar 3
Genoa 3
Hanoi 3
Hobart 3
Indiana 3
Kilburn 3
Lanzhou 3
Leiden 3
Livorno 3
Moscow 3
Mozzo 3
Padova 3
Totale 7.991
Nome #
Diagnosis of bloodstream infections by mass spectrometry : present and future 178
Direct inoculation of positive blood cultures using the Phoenix system for antimicrobial susceptibility testing of both Gram-positive and Gram-negative bacteria 152
Antimicrobial Activity of a New Aloe vera Formulation for the Hygiene of the Periocular Area 151
A comparison of skin storage methods for oculoplastic surgery 150
Identification and Pathogenic Potential of Clinical Bacillus and Paenibacillus Isolates 147
Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes 145
Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy 144
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 143
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. 140
Radiopharmaceuticals: new antimicrobial agents 139
Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains 139
Recent advances in the microbiological diagnosis of bloodstream infections 138
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 138
Effects of Pseudomonas aeruginosa on immune functions. 136
Antifungal effect of the antimicrobial peptide hLF(1-11) on invasive infections with Candida albicans. 136
90. CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 134
Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections 132
Identification of Candida albicans karyotypes characterized by a high proteolytic activity. 129
Comparative evaluation of six chromogenic media for presumptive yeast identification 128
Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11 127
Comparative evaluation of antimicrobial activity of different types of ionic liquids 125
Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice. 122
Detection of fungal infections using radiolabeled antifungal agents 121
CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis 121
Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin 120
Pushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification 118
Molecular basis of resistance to azole antifungals. 117
Human antimicrobial peptides’ antifungal activity against Aspergillus fumigatus 115
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg 114
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases 114
Candidacidal activities of human lactoferrin peptides derived from the N terminus 112
A new culture-based method for rapid identification of microorganisms in polymicrobial blood cultures by MALDI-TOF 111
The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters 110
Characterization of the chemotaxis fliY and cheA genes in Bacillus cereus 109
Technetium-99m labeled cationic antimicrobial peptides for infection detection and treatment monitoring 107
Graves’ orbitopathy presenting after botulinum toxin injections 107
Molecular targeted treatments for fungal infections: the role of drug combinations 107
Reactivation of Graves' Orbitopathy after Rehabilitative Orbital Decompression 107
Molecular monitoring of Candida albicans infections in liver transplant recipients 104
A Rapid Procedure for Identification and Antifungal Susceptibility Testing of Yeasts From Positive Blood Cultures 103
Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections 101
99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus 101
Control of Candida albicans murine vaginitis by topical administration of polycarbophil-econazole complex 101
Rapid and reliable identification of Gram-negative bacteria and Gram-positive cocci by deposition of bacteria harvested from blood cultures onto the MALDI-TOF plate. 101
FlhF Is Required for Swarming Motility and Full Pathogenicity of Bacillus cereus 101
Anti-biofilm Activity of the synthetic peptide hLF 1-11 against different Candida species in Lumen Catheters. 101
Evaluation of a multiplex Real-Time PCR assay for the diagnosis of human intestinal protozoa in Azienda Ospedaliero Universitaria Pisana 100
Caratterizzazione genotipica di Candida albicans 99
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 99
Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin 98
A comparison for skin storage methods for oculoplastic surgery 98
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species 98
CORT0C04210 is required for Candida orthopsilosis adhesion to human buccal cells 98
Pulmonary sporotrichosis with hyphae in a human immunodeficiency virus-infected patient. A case report. 96
Radiotracers for fungal infection imaging 96
Internal thiols and reactive oxygen species in the candidacidal activity exerted by a N-terminal peptide of human lactoferrin. 96
Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41 95
From positive blood culture to microbiological diagnosis in 4 hours by MALDI-TOF mass spectrometry bacterial identification and rapid antibiogram. 95
99mTc-labelled antimicrobial peptides for detection of bacterial and Candida albicans infections 95
null 95
Identification of Bacillus species: Implication on the quality of probiotic formulations 95
99mTc-Antimicrobial peptides: promising candidates for infection imaging 94
MALDI-TOF MS Applications to the Detection of Antifungal Resistance: State of the Art and Future Perspectives 94
Imaging of infections with Candida albicans with 99mTc-labelled antimicrobial peptides and the antifungal agent fluconazole. 93
Radiolabelled antimicrobial peptides for infection detection 91
Identification of Candida albicans karyotypes characterized by a high proteolytic activity 90
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area 90
null 86
Radiochemical and biological characteristics of Technetium-99m labelled fluconazole 85
Rapid identification and antibiotic susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 System 85
A new rapid method for direct antimicrobial susceptibility testing of bacteria from positive blood cultures 84
null 82
Diagnosi batteriologica 80
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 80
Proteolytic activity and SAP gene expression in Candida albicans strains having different karyotypes 79
MOLECULAR TYPING OF CANDIDA-ALBICANS IN ORAL CANDIDIASIS - KARYOTYPE EPIDEMIOLOGY WITH HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS IN COMPARISON WITH THAT WITH HEALTHY CARRIERS 78
Comparison of molecular typing methods for Candida albicans strain delineation. 77
Maternal anthropometric variables and clinical factors shape neonatal microbiome 75
Recent advances and ongoing challenges in the diagnosis of microbial infections by MALDI-TOF mass spectrometry 73
In vitro assessment of probiotic attributes for strains contained in commercial formulations 72
Saponin promotes rapid identification and antimicrobial susceptibility profiling of Gram-positive and Gram-negative bacteria in blood cultures with the Vitek 2 system 72
Letter to the Editor 70
Rapid detection of carbapenem resistant Klebsiella pneumoniae directly from positive blood cultures during an outbreak, in the Tuscany region in Italy. 70
Letter to the Editor 67
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert 67
Technetium-99m labelled antimicrobial peptides and anti-infectives for the detection of bacterial and Candida albicans infections. 66
Role of cpals4790 and cpals0660 in candida parapsilosis virulence: evidence from a murine model of vaginal candidiasis 65
Letter to the Editor 63
Radiochemical characteristics and biological testing of technetium-99m labelled antimicrobial cationic peptides for infection detection. 63
Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation 62
In vitro resistance and evolution of resistance to tavaborole in Trichophyton rubrum 62
Metodo per la diagnosi rapida in emocoltura di una batteriemia/setticemia 59
Horizontal transmission of Candida paraspsilosis candidemia in a naonatal intensive care unit 59
Synergistic activity between colistin and the ionic liquids 1-methyl-3 dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, or 1 dodecyl-1-methylpiperidinium bromide against Gram-negative bacteria 57
Malattie sessualmente trasmesse. Diagnosi di laboratorio. 56
Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infections 56
Radiochemical characteristics and infection imaging with UBI 29-41 peptide labelled directly and indirectly with 99mTechnetium. 54
Diagnosi batteriologica. 54
Spotlight on the Compositional Quality of Probiotic Formulations Marketed Worldwide 51
Sorveglianza microbiologica in pazienti immunocompromessi. 50
Totale 9.960
Categoria #
all - tutte 28.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019449 0 0 0 0 0 0 0 0 0 0 242 207
2019/20201.897 248 128 93 129 195 200 247 148 187 125 158 39
2020/20211.189 81 48 61 98 103 85 72 117 156 73 106 189
2021/20221.256 28 86 16 97 189 154 36 75 80 66 50 379
2022/20231.829 202 193 114 221 244 207 15 136 331 14 131 21
2023/20241.258 139 163 166 106 237 265 43 35 39 65 0 0
Totale 10.859